Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Introduction: The United States Preventative Services Task Force (USPSTF) recommended against routine prostate-specific antigen (PSA)-based prostate cancer (PCa) screening, initially for men older than 75 years in 2008, and then for all men in 2012. We evaluated the incidence of metastatic prostate cancer (mPCa) before and after the USPSTF recommendations against routine PCa screening.Methods:...

  • more data on rise in metastatic prostate cancer diagnosis with decrease in PSA screening